Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners. The company was formed in 2019 through the merger of Henry Schein Animal Health and Vets First Choice. It provides a comprehensive suite of solutions including supply chain distribution, software services, and prescription management to veterinary professionals. Covetrus serves over 100,000 customers globally, focusing on companion animal, equine, and large-animal markets. By integrating technology with pharmaceutical distribution, the company aims to improve clinical outcomes and practice profitability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Henry Schein Animal Health.